GlaxoSmithKline PLC ADR

Stock Chart, Company Information, and Scan Results

$40.78(as of Sep 9, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

GlaxoSmithKline PLC ADR Company Information, Fundamentals, and Technical Indicators

Stock Price$40.78
Ticker SymbolGSK
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - General
Employees68,629
CountyUSA
Market Cap$80,643.5M
EBIDTA9,291.0M
10-Day Moving Average39.81
P/E Ratio24.48
20-Day Moving Average39.57
Forward P/E Ratio7.71
50-Day Moving Average38.30
Earnings per Share2.23
200-Day Moving Average36.50
Profit Margin18.07%
RSI62.98
Shares Outstanding2,013.6M
ATR0.75
52-Week High42.16
Volume9,419,425
52-Week Low30.68
Most Recent Support Level39.37
Book Value14,354.0M
Most Recent Resistance Level40.71
P/B Ratio5.84
Upper Keltner41.26
P/S Ratio2.65
Lower Keltner37.89
Debt-to-Equity Ratio41.26
Next Earnings Date10/29/2025
Cash Surplus-16,779.0M
Next Ex-Dividend DateUnknown

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in London, United Kingdom.

GlaxoSmithKline PLC ADR In Our Stock Scanner

As of Sep 10, 2025
example chart graphic
Scan Name: Uptrending StocksScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.